Datasheets

Remyelination has become the most interesting frontier in multiple sclerosis. The approved therapies for relapsing...

AAALAC accreditation carries practical weight in preclinical drug development, and its implications for program quality...

Botulinum toxin type A has been established as a therapeutic agent in spasticity, dystonia, and cosmetic indications...

Spinal cord injury presents one of the most challenging translational profiles in central nervous system drug...

GLP-1 receptor agonists have substantially reshaped the therapeutic landscape for type 2 diabetes and obesity, and the...